IFX anti-TNF therapy associated with clinical benefit over 5 years in patients with active AS
... therapy, 61.8% of patients with ankylosing
spondylitis (AS) showed substantial clinical benefit (ASAS40, ... 96-week open-label EASIC (European
Ankylosing
spondylitis Infliximab Cohort) trial had previously ... randomised controlled trial ASSERT (Ankylosing
spondylitis Study for the Evaluation of Recombinant ...
SIMPONI(TM) (golimumab) Receives FDA Approval as First Once-Monthly Anti-TNF for Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis
... arthritis, psoriatic arthritis and ankylosing
spondylitis are chronic inflammatory diseases that result in ... arthritis, psoriatic arthritis and ankylosing
spondylitis who had previously received a wide variety of ... of adult patients with active ankylosing
spondylitis
SIMPONI is available in two ...
Increased cancer risk following the use of radioactive Radium-224 in the therapy
... Ankylosing
spondylitis (Bechterew's Disease) is a painful chronic ... a long-term follow-up study of 1,471 ankylosing
spondylitis patients, whose disease symptoms were treated ... 224Radium. A control cohort of 1,324 ankylosing
spondylitis patients treated without the use of radioactive ...
Data Show that Abbott's HUMIRA(R) (adalimumab) Reduced the Signs and Symptoms of Ankylosing Spondylitis Up to Three Years
... in Paris.
"There is no cure for ankylosing
spondylitis and the goal of therapy is
to relieve back and ... death caused by malignancy.
About Ankylosing
spondylitis (AS)
AS is a rheumatic condition that affects ... men than in women. Ankylosis means "fusion" and
spondylitis means
"inflammation of the spine." Advanced AS ...
Adalimumab therapy effective in AS, RA and PsA patients refractory to other anti-TNF therapies
... is effective and well-tolerated in ankylosing
spondylitis (AS), rheumatoid arthritis (RA) and psoriatic ... have a mean reduction in BASDAI (Bath Ankylosing
spondylitis Disease Activity Index) of -2.4 following ... options for their diseases."
Ankylosing
spondylitis
61% of AS patients who had lost their initial ...
Abbott Study Examines Rates of Uveitis (Inflammation of the Eye) in Ankylosing Spondylitis Patients Treated with HUMIRA(R) (adalimumab)
... Percent of People with Ankylosing
spondylitis (Spinal Arthritis)
ABBOTT PARK, Ill., Nov. 8 /PRNewswire-FirstCall/ -- A study of
ankylosing
spondylitis (AS) patients treated with Abbott's HUMIRA(R) ... to
patients treated with placebo. Ankylosing
spondylitis is an inflammatory
disease of the spine, and may ...
UT rheumatologists discover 2 genes related to disabling form of arthritis
... of Queensland, led research done by the Triple A
spondylitis Consortium Genetic Study (i.e. the TASC or Australo-Anglo-American
spondylitis Consortium).
The international team of ... steps closer to fully understanding ankylosing
spondylitis or AS, a chronic form of arthritis that attacks ...
LegalView Informs Patients of Possible Cimzia Cancer Link, Drug Commonly Used to Treat Arthritis
... rheumatoid/psoriatic arthritis, Crohn's disease, psoriasis, ankylosing
spondylitis and juvenile idiopathic arthritis -- should speak to a medical ... juvenile idiopathic arthritis, psoriatic arthritis, ankylosing
spondylitis and plaque psoriasis. In addition to the potential for causing possibly ...
New Long-Term HUMIRA(R) (adalimumab) Data Show Up to Seven-Year Efficacy with Combination Treatment for Rheumatoid Arthritis
... arthritis (RA), psoriatic arthritis (PsA), plaque
psoriasis, ankylosing
spondylitis (AS) and Crohn's disease in the United
States and Europe. HUMIRA resembles ... is indicated for the treatment of adults with severe, active
ankylosing
spondylitis who have had an inadequate response to conventional
therapy.
HUMIRA is ...
HUMIRA(R) (adalimumab) Data Show That Treating Early Rheumatoid Arthritis With Combination Treatment Resulted in Cost Savings From Improved Work Productivity
... arthritis (RA), psoriatic arthritis (PsA), plaque
psoriasis, ankylosing
spondylitis (AS) and Crohn's disease in the United
States and Europe. HUMIRA resembles ... is indicated for the treatment of adults with severe, active
ankylosing
spondylitis who have had an inadequate response to conventional
therapy.
HUMIRA is ...
More>>
Spondylitis in Medical Technology
SIMPONI(TM) (golimumab) Receives Positive Opinion From CHMP for Once-Monthly Subcutaneous Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis
... arthritis (PsA) and severe, active ankylosing
spondylitis (AS).
Upon Commission approval in the ... arthritis, psoriatic arthritis and ankylosing
spondylitis in the European Union," said Jerome A. Boscia, ... of their productive years.
About Ankylosing
spondylitis
...
Two-Year Data Show Patients Receiving SIMPONI(TM) (golimumab) Experienced Sustained Improvement in Signs and Symptoms of Psoriatic Arthritis and Ankylosing Spondylitis
... with psoriatic arthritis (PsA) and ankylosing
spondylitis (AS). Investigators reported these new data from ... Go limumab - A R andomized Study in A nkylosing
spondylitis Subjects of a Novel Anti-TNF mAB I njection ( S ... Improvements in the Assessment in Ankylosing
spondylitis criteria (ASAS 20) were maintained through two ...
New Anti-TNF Golimumab Significantly Reduced Signs and Symptoms of Ankylosing Spondylitis According to Phase 3 Study Findings
... six months as measured
by the Bath Ankylosing
spondylitis Functional Index (BASFI). Golimumab, Centocor ... the Golimumab - A Randomized Study in
Ankylosing
spondylitis Subjects of a Novel Anti-TNF mAB Injection ... defined as 40 percent
improvement in ankylosing
spondylitis signs and symptoms, compared with 15
percent of ...
CHMP Recommends Approval of New Indication for Enbrel(R) as Treatment for Severe Psoriasis in Paediatric Patients
... with polyarticular
symmetrical subtypes of the disease.
Ankylosing
spondylitis
Treatment of adults with severe active ankylosing
spondylitis who have
had an inadequate response to conventional therapy.
...
New Analysis Shows Efficacy of SIMPONI(TM) (golimumab) in Anti-TNF Experienced Rheumatoid Arthritis Patients
... in adults, in combination with methotrexate; active psoriatic arthritis in adults, alone or in combination with methotrexate; and active ankylosing
spondylitis in adults.
Indications in Canada:
In Canada, SIMPONI, in combination with methotrexate (MTX), is indicated for reducing the signs and ...
New One-Year Data from REMICADE(R) SONIC Trial Show Sustained Efficacy Compared with Azathioprine in Treatment of Crohn's Disease
... and dermatology. REMICADE has demonstrated broad clinical utility with indications in Crohn's disease (CD), rheumatoid arthritis (RA), ankylosing
spondylitis (AS), psoriatic arthritis (PsA), ulcerative colitis (UC), pediatric Crohn's disease (PCD) and psoriasis (PsO). The safety and efficacy of REMICADE ...
Schering-Plough Highlights R&D Pipeline Progress, Innovation and Breadth of Research Projects
... a once-monthly subcutaneous anti-TNF agent for inflammatory and autoimmune disorders (under review in EU for rheumatoid arthritis, ankylosing
spondylitis and psoriatic arthritis, and in Phase III for ulcerative colitis); Schering-Plough has exclusive marketing rights to golimumab outside the U.S. ...
Continuous Treatment With Abbott's HUMIRA(R) Achieves Superior Long-Term Efficacy for Psoriasis Patients Compared to Interrupting Treatment
... is the only fully human monoclonal antibody approved for the
treatment of rheumatoid arthritis (RA), psoriatic arthritis (PsA),
psoriasis, ankylosing
spondylitis (AS), Crohn's disease and juvenile
idiopathic arthritis (JIA) in the United States and Europe. HUMIRA
resembles antibodies normally found in the ....
Abbott's HUMIRA(R) (adalimumab) Receives FDA Approval For Moderate to Severe Chronic Plaque Psoriasis
... with rheumatoid arthritis patients. It was
approved for moderate to severe rheumatoid arthritis in 2002, psoriatic
arthritis in 2005, ankylosing
spondylitis in 2006, and moderate to severe
Crohn's disease in 2007.
"The approval of HUMIRA for psoriasis is welcome news for people living
with this ...
Arthritis Foundation Announces Amgen and Wyeth to Be Presenting Sponsor of the 2008 Arthritis Walk (R)
... of Amgen, manufactures ENBREL, which
may be used to treat rheumatoid arthritis, junior rheumatoid arthritis,
psoriatic arthritis, ankylosing
spondylitis and psoriasis. Additional
information about ENBREL, including the full U.S. Prescribing Information,
can be found on the Web site sponsored by the ...
More>>
Spondylitis in Medical Products
Clinical Neurology 2007
Description:... strokes, headaches, coma, cervical spine problems, low back pain, radiculopathy, sciatica, myofacial pain, sacroiliac dysfunction, ankylosing
spondylitis and pseudo-neurological syndromes. To help you manage and treat anything that walks through the door. It is constantly updated, adding the latest and ...
Company:Mobipocket.com
Spondylitis in Medical Dictionary
Ankylosing spondylitis
... Ankylosing
spondylitis is one of many forms of inflammatory arthritis ... which is rheumatoid arthritis . Ankylosing
spondylitis Definition:
spondylitis involves inflammation of one or more ...
Sacroiliac
... non- arthritis symptoms ... Ankylosing
spondylitis - Explains Ankylosing
spondylitis (a form of chronic inflammation of the spine ... back; it is called lumbago.) ... Ankylosing
spondylitis , involves the sacroiliac joint - the one ...
Spondylitis
...
spondylitis involves inflammation of one or more vertebrae . Ankylosing
spondylitis is a chronic inflammatory disease that ... the spine and the pelvis . Ankylosing
spondylitis is one of many forms of inflammatory arthritis ...
Heel Spurs
... ( inflammation of the joints ) such as Reiter's disease , ankylosing
spondylitis , and diffuse idiopathic skeletal hyperostosis. Heel spurs (also called bone spurs) Inflammatory conditions (e.g., ankylosing
spondylitis , diffuse idiopathic skeletal hyperostosis, rheumatoid arthritis , ...
Idiopathic
... Skeletal Hyperostosis? ( Other Names: Ankylosing hyperostosis,
spondylitis ossificans ligament osa, Vertebral osteophytosis) ... Idiopathic ... the nerve s and muscle s, such as muscular dystrophy . ankylosing
spondylitis , diffuse idiopathic skeletal hyperostosis, rheumatoid arthritis , ...
Iritis
...... Another serious problem that can result in patients with ankylosing
spondylitis is iritis , or inflammation of the eye . Many people with ankylosing
spondylitis experience this problem, which cases redness and pain , and sensitivity ...
Juvenile Rheumatoid Arthritis
... (SLE) Gout Scleroderma Psoriatic arthritis Ankylosing
spondylitis Reiter's syndrome (reactive arthritis ) Adult Still's disease ... arthritis ) Fungal infection s such as blasto mycosis Ankylosing
spondylitis Reiter's syndrome /Reactive arthritis Septic arthritis Adult ...
Osteoarthritis
... arthritis ) Fungal infection s such as blasto mycosis Ankylosing
spondylitis ... Osteoarthritis may be more likely to develop if you abuse your ... or teeth stress ... Disease s such as spinal osteoarthritis ,
spondylitis and compress ion fractures can also cause pain . Some of these ...
Psoriatic arthritis
... rheumatoid arthritis (which see), gout (which see), and ankylosing
spondylitis (which see). Other disease s which also infect the joints include ... of arthritis . (see osteoarthritis , rheumatoid arthritis , ankylosing
spondylitis , psoriatic arthritis , lupus , gout , pseudogout ). ...
Aortic dissection
... endocarditis (valve infection ), high blood pressure , Marfan's syndrome , aortic dissection (a tear in the lining of the aorta ), ankylosing
spondylitis , ... mitral valve prolapse arrhythmia (or dysrhythmia) aortic regurgitation aortic dissection ... Note: Aneurysm s may develop ...
More>>
Spondylitis in Biological News
Study reveals 2 genes linked to disabling arthritis
... Consortium and The Australo-Anglo-American
spondylitis Consortium reported their findings online Oct. 21 ... to have a higher probability of having ankylosing
spondylitis and psoriasis. The IL23R gene provides a genetic ... factor for both Crohns disease and ankylosing
spondylitis suggests that drugs being tested for one also may ...
Major genetic breakthrough for ankylosing spondylitis brings treatment hope
... also be applied to this disease.
Ankylosing
spondylitis affects as many as 1 in 200 men and 1 in 500 ... DNA samples from 1,000 patients with ankylosing
spondylitis and a further 1,500 people unaffected by the ... led by Professor John Reveille.
"Ankylosing
spondylitis is a painful and often very disabling disease," ...
Johnson & Johnson honors 2008 recipients of the Dr. Paul Janssen Award for Biomedical Research
... 80 types of autoimmune diseases including rheumatoid arthritis, ankylosing
spondylitis and ulcerative colitis. The safety and efficacy of anti-TNF therapies has ... subsequently led to TNF blockade in Crohn's disease, psoriasis, ankylosing
spondylitis and ulcerative colitis," said Feldmann. "Blocking other cytokines such ...
Clinical studies show REMICADE reduces incidence of bowel surgeries in ulcerative colitis patients
... rheumatology and dermatology. REMICADE has demonstrated broad clinical utility in Crohn's disease (CD), rheumatoid arthritis (RA), ankylosing
spondylitis (AS), psoriatic arthritis (PsA), ulcerative colitis (UC), pediatric Crohns disease (PCD) and psoriasis (PsO). The safety and efficacy of REMICADE ...
Spondylitis in Biological Technology
Health Canada Approves SIMPONI(TM) (golimumab) for Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis
... psoriatic arthritis (PsA)
and active ankylosing
spondylitis (AS). With this approval in Canada,
SIMPONI, in ... their productive years.
About Ankylosing
spondylitis
Ankylosing
spondylitis is a painful and progressive form of ...
Johnson & Johnson Honors 2008 Recipients of The Dr. Paul Janssen Award for Biomedical Research
... 80 types of autoimmune diseases including
rheumatoid arthritis, ankylosing
spondylitis and ulcerative colitis. The
safety and efficacy of anti-TNF therapies has ... subsequently led to TNF
blockade in Crohn's disease, psoriasis, ankylosing
spondylitis and
ulcerative colitis," said Feldmann. "Blocking other cytokines such as ...
Centocor, Inc. and Schering-Plough Submit Application Requesting Approval of Golimumab in Europe for the Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis
... (GO-REVEAL) trial and
the Golimumab - A Randomized Study in Ankylosing
spondylitis Subjects of a
Novel Anti-TNF mAB Injection (SC) Given Every Four Weeks ... of their productive years.
About Ankylosing Spondylitis
Ankylosing
spondylitis (AS) is a painful and progressive form of spinal
arthritis and symptoms of ...
REMICADE(R) Becomes First Anti-TNF Biologic Therapy to Treat One Million Patients Worldwide
... inhibitor approved in the EU for the treatment of ankylosing
spondylitis in patients who have severe axial symptoms, elevated serological ... play a role in Crohn's disease (CD), rheumatoid
arthritis (RA), ankylosing
spondylitis (AS) psoriatic arthritis (PsA),
ulcerative colitis (UC), pediatric Crohn's ...
Professors Marc Feldmann and Sir Ravinder Maini Named Winners of the 2008 Dr. Paul Janssen Award for Biomedical Research
... target for treatment not only in rheumatoid arthritis but also
other chronic inflammatory conditions, such as inflammatory bowel disease,
ankylosing
spondylitis and psoriasis. This discovery suggested that other
cytokine messenger molecules are also good treatment targets and has led to
an emerging branch of ...
Abbott's HUMIRA(R) Receives Positive Opinion From EMEA for Treatment of Moderate to Severe Plaque Psoriasis
... HUMIRA is the only fully human monoclonal antibody approved for the
treatment of rheumatoid arthritis (RA), psoriatic arthritis (PsA),
ankylosing
spondylitis (AS) and Crohn.s disease in the United States and
Europe. HUMIRA resembles antibodies normally found in the body. It works by
blocking tumor necrosis ...